Nevertheless, one has to keep in mind that testosterone replacement therapy in hypogonadal diabetic males is related to an improvement of insulin sensitivity in patients with T2DM, metabolic syndrome or both [16]. This evidence concerns the gene INS and metabolic syndrome.